WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
At least 40 people die in Kenya after dam collapses
Two in custody after armed police swarm Auckland suburb
Whale euthanised after stranding near Christchurch
Interislander ferry upgrade: Finance Minister warns of cost blowout
Chinese enterprises keen to expand int'l market: Trade council
UN Security Council passes resolution calling for Gaza ceasefire
Whale euthanised after stranding near Christchurch
Department of Conservation set to lose scientific expertise in job cuts
Immersive Studio Ghibli exhibition opens in Shanghai
Nikki Haley Wins District of Columbia's Republican Primary, Gets Her First 2024 Victory
Songs of celebration hail anniversary
Ukraine war: Five dead and a million without power after wave of Russian strikes